A Phase 1 Study of SY-5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors

Clinical Trial Grant

Duke Scholars

Principal Investigator Niharika Bansal Mettu Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

SYROS PHARMACEUTICALS

Start Date

April 28, 2021

End Date

May 26, 2026

Administered By

Duke Cancer Institute

Awarded By

SYROS PHARMACEUTICALS

Start Date

April 28, 2021

End Date

May 26, 2026